Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Fonteyne, Valérie" or (type exact bookEditor and editor="Fonteyne, Valérie")

Mark
- journalArticle
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma

Nora Sundahl (UGent) , Gillian Vandekerkhove, Karel Decaestecker (UGent) , Annabel Meireson (UGent) , PIETER DE VISSCHERE (UGent) , Valérie Fonteyne, Daan De Maeseneer (UGent) , Dries Reynders (UGent) , Els Goetghebeur (UGent) , Jo Van Dorpe (UGent) , et al.

(2019) European Urology.
Mark
- misc
Current insights in the management of high-risk prostate cancer : still more questions than answers

Valerie Fonteyne (UGent) and Piet Ost (UGent)

(2019) EUROPEAN UROLOGY. 75(1). p.61-62
Mark
- journalArticle
- A1
Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and oncological outcomes

Andries Van Huele, Filip Poelaert (UGent) , Valerie Fonteyne (UGent) , Karel Decaestecker (UGent) , Piet Ost (UGent) and Nicolaas Lumen (UGent)

(2019) ACTA CHIRURGICA BELGICA.
Mark
Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study

Elke Rammant (UGent) , Valerie Fonteyne (UGent) , Karel Decaestecker (UGent) , Renée Bultijnck (UGent) , Benedicte Deforche (UGent) , Ronny Pieters (UGent) , Piet Ost (UGent) , Sofie Verhaeghe (UGent) and Ann Van Hecke (UGent)

(2019) CLINICAL REHABILITATION.
Mark
Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer

Sarah Buelens (UGent) , Elise De Bleser (UGent) , Bert Dhondt (UGent) , Wesley Verla (UGent) , Karel Decaestecker (UGent) , Piet Ost (UGent) , Valerie Fonteyne (UGent) , Kathia De Man (UGent) , Chloë Standaert (UGent) , Sylvie Rottey (UGent) , et al.

(2019) WORLD JOURNAL OF UROLOGY.
Mark
- misc
Selecting candidates for early discharge after radical cystectomy for bladder cancer

Valerie Fonteyne (UGent) , Elke Rammant (UGent) and Karel Decaestecker (UGent)

(2018) TRANSLATIONAL ANDROLOGY AND UROLOGY. 7(suppl. 1). p.S86-S89
Mark
- journalArticle
- A1
A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy

Elke Rammant (UGent) , Karel Decaestecker (UGent) , Renée Bultijnck (UGent) , Nora Sundahl (UGent) , Piet Ost (UGent) , Nele Pauwels (UGent) , Benedicte Deforche (UGent) , Ronny Pieters (UGent) and Valerie Fonteyne (UGent)

(2018) CLINICAL REHABILITATION.
Mark
- journalArticle
- open access
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time

Bert Dhondt (UGent) , Elise De Bleser (UGent) , Tom Claeys, Sarah Buelens (UGent) , Nicolaas Lumen (UGent) , Jo Vandesompele (UGent) , Anneleen Beckers, Valerie Fonteyne (UGent) , Kim Van der Eecken (UGent) , Aurélie De Bruycker (UGent) , et al.

(2018) World Journal of Urology.
Mark
- journalArticle
- open access
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial

Sarah Buelens (UGent) , Filip Poelaert (UGent) , Bert Dhondt (UGent) , Valerie Fonteyne (UGent) , Pieter De Visschere (UGent) , Piet Ost (UGent) , Sofie Verbeke (UGent) , Geert Villeirs (UGent) , Kathia De Man (UGent) , Sylvie Rottey (UGent) , et al.

(2018) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 36(4). p.158.e13-158.e20
Mark
4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Valerie Fonteyne (UGent) , Camille Sarrazyn, Martijn Swimberghe (UGent) , Gert De Meerleer (UGent) , Elke Rammant (UGent) , Barbara Vanderstraeten (UGent) , Frank Vanpachtenbeke (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Roos Colman (UGent) , et al.

(2018) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 100(4). p.866-870

Academic Bibliography

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma

Current insights in the management of high-risk prostate cancer : still more questions than answers

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and oncological outcomes

Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study

Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer

Selecting candidates for early discharge after radical cystectomy for bladder cancer

A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial

4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Contents

Support

Contact